Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. | Breast Cancer Res Treat;147(2): 423-31, 2014 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells.

Wei, Yifang; Lai, Xiaofeng; Yu, Shentong; Chen, Suning; Ma, Yongzheng; Zhang, Yuan; Li, Huichen; Zhu, Xingmei; Yao, Libo; Zhang, Jian.

Affiliation

Wei Y; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, 710032, Shaanxi, China.

Breast Cancer Res Treat ; 147(2): 423-31, 2014 Sep.

Article in En | MEDLINE | ID: mdl-25007959

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / MicroRNAs / Estrogen Receptor alpha / Exosomes Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2014 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / MicroRNAs / Estrogen Receptor alpha / Exosomes Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2014 Document type: Article Affiliation country: